Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATORVASTATIN Cause Toxic epidermal necrolysis? 124 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Toxic epidermal necrolysis have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.2% of all adverse event reports for ATORVASTATIN.

124
Reports of Toxic epidermal necrolysis with ATORVASTATIN
0.2%
of all ATORVASTATIN reports
48
Deaths
108
Hospitalizations

How Dangerous Is Toxic epidermal necrolysis From ATORVASTATIN?

Of the 124 reports, 48 (38.7%) resulted in death, 108 (87.1%) required hospitalization, and 34 (27.4%) were considered life-threatening.

Is Toxic epidermal necrolysis Listed in the Official Label?

Yes, Toxic epidermal necrolysis is listed as a known adverse reaction in the official FDA drug label for ATORVASTATIN.

What Other Side Effects Does ATORVASTATIN Cause?

Type 2 diabetes mellitus (7,556) Myalgia (7,155) Drug hypersensitivity (3,929) Drug ineffective (3,865) Fatigue (3,439) Arthralgia (3,338) Rhabdomyolysis (3,286) Dyspnoea (3,137) Nausea (2,888) Asthenia (2,791)

What Other Drugs Cause Toxic epidermal necrolysis?

ACETAMINOPHEN (980) LAMOTRIGINE (941) ALLOPURINOL (858) IBUPROFEN (764) SULFAMETHOXAZOLE\TRIMETHOPRIM (592) CIPROFLOXACIN (576) FUROSEMIDE (521) VANCOMYCIN (515) PIPERACILLIN\TAZOBACTAM (490) PEMBROLIZUMAB (444)

Which ATORVASTATIN Alternatives Have Lower Toxic epidermal necrolysis Risk?

ATORVASTATIN vs ATORVASTATIN\EZETIMIBE ATORVASTATIN vs ATOSIBAN ATORVASTATIN vs ATOVAQUONE ATORVASTATIN vs ATOVAQUONE\PROGUANIL ATORVASTATIN vs ATRACURIUM

Related Pages

ATORVASTATIN Full Profile All Toxic epidermal necrolysis Reports All Drugs Causing Toxic epidermal necrolysis ATORVASTATIN Demographics